Kane Biotech Inc KNBIF

Primary Symbol: V.KNE

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.

TSXV:KNE - Post by User

Kane Biotech Inc > New Press Release - Kane Biotech Announces Distribution Agreement with Qatar Datamation Systems for revyve(TM) Antimicrobial Wound Gel

<< Previous

Bullboard Posts

Next >>

Comment by RoyMax123on Aug 28, 2024 8:52am

29 Views

Post# 36199043

RE:New Press Release - Kane Biotech Announces Distribution Agreement with Qatar Datamation Systems for revyve(TM) Antimicrobial Wound Gel

I don't get why they didn't went for a big player who can distribute world wide instead of cherry picking multiple little distributors around the globe. That may become more hard and costly to manage that way.

<< Previous

Bullboard Posts

Next >>

A PGM mining stock with value written all over it